PCRCX | PCRNX | PCRCX / PCRNX | |
Total Expense Ratio | 2.10 | 1.05 | 200% |
Annual Report Gross Expense Ratio | 2.18 | 1.18 | 185% |
Fund Existence | 23 years | 7 years | - |
Gain YTD | 9.870 | 10.661 | 93% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 1000000 | 0% |
Min. Initial Investment IRA | 1000 | N/A | - |
Net Assets | 3.43B | 3.43B | 100% |
Annual Yield % from dividends | 4.37 | 4.36 | 100% |
Returns for 1 year | 14.34 | 15.57 | 92% |
Returns for 3 years | -1.93 | 1.17 | -165% |
Returns for 5 years | 62.31 | 70.90 | 88% |
Returns for 10 years | 38.97 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
IYPCX | 20.89 | 0.13 | +0.63% |
Macquarie Systematic Em Mkts Eq R | |||
ADNRX | 20.74 | 0.12 | +0.58% |
American Beacon ARK Transfmt Innov R6 | |||
BMGAX | 35.93 | 0.10 | +0.28% |
BlackRock Mid-Cap Growth Equity Inv A | |||
AIHHX | 7.24 | N/A | N/A |
Aristotle Small/Mid Cap Equity I-2 | |||
JIGZX | 89.05 | -0.23 | -0.26% |
JPMorgan U.S. GARP Equity R2 |